Non-Executive Directors' Shar

RNS Number : 8039T

Deltex Medical Group PLC

12 June 2009

 



Deltex Medical Group plc

Non- Executive Directors' Shareholdings

12 June 2009 

Deltex Medical Group plc ('the Company'), the global leader in oesophageal Doppler monitoring ('ODM'), announces that it has today issued a total of 370,002 new ordinary shares of 1p each in the Company ('New Ordinary Shares') to its non-executive directors of the Company at a price of 12.75 pence per share.

The four non-executive directors named below have elected to take shares in lieu of a cash payment as remuneration for their services to the Company for the period 1 September 2008 to 31 March 2009.

Accordingly, application has been made for these shares to be admitted to trading on AIM. The shares rank pari passu with the existing issued shares of the Company and dealings are expected to commence on 18 June 2009. Following the issue of these new shares the Company has a total of 101,390,613 ordinary shares of 1p each in issue.

Following this issue, the directors' beneficial interests are as follows:

Name of Director	Number of New Ordinary Shares issued in lieu of fees	Holding of shares following issue of New Ordinary Shares	% of enlarged issued share capital
Nigel Keen	130,718	4,122,972	4.07
Dr Edwin Snape (1)	94,118	4,072,921	4.02
Sir Duncan Nichol	75,294	369,691	0.36
Julian Cazalet	69,872	1,889,744	1.86

(1)    Includes shares held as a principal of Nexus Medical Partners II, L.P.

 For further information, please contact:-

Deltex Medical Group plc                            01243 774 837
Nigel Keen, Chairman                 
Andy Hill, Chief Executive            
Ewan Phillips, Finance Director        

Nominated Adviser and Broker                        0207 398 1600

Arden Partners plc  

Christopher Hardie

Matthew Armitt

 

END

 

 

RDSGIGDLLDBGGCD